Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Targeting Angiogenesis Using Bevacizumab Combined With Chemotherapy and Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas

NCT01106872 is registered in ClinicalTrials.gov with Mohammed M Milhem as lead sponsor.

NCT NCT01106872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Targeting Angiogenesis Using Bevacizumab Combined With Chemotherapy and Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
Lead sponsor
Mohammed M Milhem
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2010
Completion date
August 22, 2017
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced sarcoma, metastatic sarcoma, sarcoma, soft tissue sarcoma, unresectable sarcoma